Where does BioAtla, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), BioAtla, Inc. ranks #7,528 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does BioAtla, Inc. hold?

BioAtla, Inc. holds 43 US utility patents granted between 2016 and 2025, spanning 12 technology areas.

What is BioAtla, Inc.'s Innovation Score?

BioAtla, Inc. has an Innovation Score of 48.1 out of 100 (top 17% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does BioAtla, Inc. focus on?

BioAtla, Inc.'s top technology area is C07K (Peptides) with 41 patents. Grants appear in 12 CPC subclasses total.

Is BioAtla, Inc.'s patent grant rate increasing or decreasing?

BioAtla, Inc.'s recent grant velocity is +142% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for BioAtla, Inc.'s patents?

BioAtla, Inc.'s patents average 20.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the BioAtla, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

BioAtla, Inc.

USPTO PatentsView assignee record - 43 granted patents across 12 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Bioatla ranks #7,528 of 49,997 tracked US assignees by granted-patent volume, with 43 patents across 12 technology areas.

#7,528
of 49,997 US assignees by volume: Top 17%
by Innovation Score (48.1/100): 20.3
avg claims per patent: +142%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7528 · US Corporation #7,528 · 43 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 43 grants
UPPER-Q #7,528/49,997
PHOTO-FINISH Balenciaga
CPC-FOCUS C07K · 12 areas
INNOV-PAR 48.1/100
CLAIMS-DENSE 20.3 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +142% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Balenciaga (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Innovia Films · near

48
Workday · near

48
Zhejiang Geely… · near

48
BioAtla · this assignee

48
YPF TECNOLOGÍA · near

48
3D Lighting… · lowest

7

What this shows Bioatla's Innovation Score is 48.1/100 (top 17% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Bioatla's grants concentrate

BioAtla, Inc. is a focused PatentsView assignee: 12 CPC subclasses with 95.3% of grants classified under C07K (Peptides). Peak complete grant year is 2018 (7 grants) versus a trough of 1 in 2016. By volume, Bioatla sits between Bongiovi Acoustic LLC and Calb Co., Ltd..

Bioatla's three-year grant acceleration

BioAtla, Inc. shows 19 grants in 2022–2024 against only 12 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Bongiovi Acoustic

43
Boston Medical Ce…

43
Balenciaga

43
Bank of Montreal

43
Bracco Suisse

43
Bruin Biometrics

43
Buster and Punch

43
Calb

43
Bioatla ◀

43

What this shows BioAtla holds 43 patents at rank #7,532, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near BioAtla

By rank, the assignees closest to #7,532 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in BioAtla's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for BioAtla, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (48 here).

YPF TECNOLOGÍA S.A. 48 Zhejiang Geely Automobile Research Institute Co., Ltd 48 Innovia Films Ltd. 48 Workday, Inc. 48

Bioatla's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

48 Top 17% higher than 83% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

BioAtla, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	2.3%
2017	2	4.7%
2018	7	16.3%
2019	2	4.7%
2020	6	14.0%
2021	4	9.3%
2022	7	16.3%
2023	7	16.3%
2024	5	11.6%
2025partial year	2	4.7%

Which technologies does BioAtla, Inc. patent most?

C07K - Peptides 41

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 27

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 26

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 24

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 22

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 13

C12Y - Enzymes 6

Y02A - Technologies FOR Adaptation TO Climate Change 6

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 3

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 3

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 1

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

Top 12 of 12 technology areas

Where it ranks

Overall rank by patents

#7,528

of 49,997 tracked assignees

Innovation Score

48.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

BioAtla, Inc.'s patent record in context - here's where to go next.

BioAtla, Inc.'s lead technology class is C07K (Peptides), 95.3% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #7,528 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare BioAtla, Inc. against Bongiovi Acoustic LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 48.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.